cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Adicet Bio Inc
8 own
16 watching
Current Price
$2.18
$-0.02
(-0.91%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
243.57M
52-Week High
52-Week High
7.50000
52-Week Low
52-Week Low
1.10000
Average Volume
Average Volume
0.03M
Dividend Yield
Dividend Yield
0.04
P/E Ratio
P/E Ratio
21.7527
iconMarket Capitalization243.57M
icon52-Week High7.50000
icon52-Week Low1.10000
iconAverage Volume0.03M
iconDividend Yield0.04
iconP/E Ratio21.7527
What does the Adicet Bio Inc do?
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors or T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable activity in patients. Its products pipeline includes ADI-001, which is in Phase 1 clinical study to treat non-Hodgkin's lymphoma; and ADI-002 that is in Phase 1 clinical study for the treatment of hepatocellular carcinoma and other solid tumors. The company is based in Boston, Massachusetts.
Read More
How much money does Adicet Bio Inc make?
News & Events about Adicet Bio Inc.
Zolmax
9 months ago
Shares of Adicet Bio, Inc. (NASDAQ:ACET Free Report) have been given a consensus recommendation of Hold by the five research firms that are covering the firm, MarketBeat.com reports. Three analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average ...
PR Newswire
9 months ago
Thinking about buying stock in Oncolytics Biotech, Nikola, American Equity Investment Life, Lordstown Motors, or Adicet Bio? Thinking about buying stock in Oncolytics Biotech, Nikola, American Equity Investment Life, Lordstown Motors, or Adicet Bio? PR Newswire NEW YORK, June 27, 2023 NEW YORK...
Ticker Report
1 year ago
Adicet Bio, Inc. (NASDAQ:ACET Get Rating) has been given a consensus recommendation of Moderate Buy by the eight ratings firms that are covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating and four have given a buy rating to...
Business Wire
1 year ago
Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer, today announced it granted inducement awards on January 31, 2023. Six individuals hired by Adicet in January 2023 received, in the aggregate...
Ticker Report
1 year ago
Shares of Adicet Bio, Inc. (NASDAQ:ACET Get Rating) have been assigned an average recommendation of Moderate Buy from the nine ratings firms that are currently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation and ...
Frequently Asked Questions
Frequently Asked Questions
What is Adicet Bio Inc share price today?
plus_minus_icon
Can Indians buy Adicet Bio Inc shares?
plus_minus_icon
How can I buy Adicet Bio Inc shares from India?
plus_minus_icon
Can Fractional shares of Adicet Bio Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Adicet Bio Inc stocks?
plus_minus_icon
What is today’s traded volume of Adicet Bio Inc?
plus_minus_icon
What is today’s market capitalisation of Adicet Bio Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Adicet Bio Inc?
plus_minus_icon
What percentage is Adicet Bio Inc down from its 52-Week High?
plus_minus_icon
What percentage is Adicet Bio Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$2.18
$-0.02
(-0.91%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00